TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
16 hedge funds and large institutions have $1.51M invested in Titan Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
37% less call options, than puts
Call options by funds: $257K | Put options by funds: $411K
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
16
Holding in Top 10
–
Calls
$257K
Puts
$411K
Top Buyers
| 1 | +$413K | |
| 2 | +$342K | |
| 3 | +$129K | |
| 4 |
VF
Virtu Financial
New York
|
+$87K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$45.7K |
Top Sellers
| 1 | -$119K | |
| 2 | -$114K | |
| 3 | -$69K | |
| 4 |
Millennium Management
New York
|
-$50K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$40.3K |